Related Experiment Video
Updated: Sep 9, 2025
05:31
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
915
Atherosclerosis after pre-eclampsia: systematic review and meta-analysis
Summary
Women who experienced pre-eclampsia have a higher prevalence of atherosclerosis, appearing approximately 10 years earlier than in women with uncomplicated pregnancies. Early cardiovascular risk management is crucial for this population.
Area of Science:
- Cardiovascular Health
- Obstetrics
- Epidemiology
Background:
- Pre-eclampsia affects up to 8% of pregnancies.
- It is linked to increased risks of ischemic heart and cerebrovascular diseases.
- Early detection of cardiovascular risk is key for prevention.
Purpose of the Study:
- To determine the prevalence of clinical and subclinical atherosclerosis in women post-pregnancy.
- To compare atherosclerosis rates between women with and without a history of pre-eclampsia.
- To analyze the impact of advancing maternal age on these rates.
Main Methods:
- A systematic literature review and meta-analysis of 11 studies (13,217 participants).
- Included studies documented systemic atherosclerosis via ultrasound or CT scans.
- Random-effects meta-analysis calculated odds ratios (OR) with 95% confidence intervals (CI).
Main Results:
- A pooled OR of 1.57 (95% CI, 1.39-1.78) for atherosclerosis post-pre-eclampsia.
- Atherosclerosis risk increased with maternal age, significantly higher in the 40-49 (OR, 1.59) and 50-60 (OR, 2.00) age groups.
- Prevalence in formerly pre-eclamptic women was similar to non-pre-eclamptic women 10 years their senior.
Conclusions:
- Women with a history of pre-eclampsia exhibit more frequent atherosclerosis, appearing about a decade earlier.
- Targeted primary prevention strategies are necessary.
- This aims to reduce premature cardiovascular disease morbidity and mortality.
Related Concept Videos
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:30Atherosclerosis I: Introduction
76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48